Back to Journals » Breast Cancer: Targets and Therapy
Breast Cancer: Targets and Therapy
ISSN: 1179-1314
- View all (424)
- Volume 15, 2023 (32)
- Volume 14, 2022 (41)
- Volume 13, 2021 (58)
- Volume 12, 2020 (27)
- Volume 11, 2019 (32)
- Volume 10, 2018 (24)
- Volume 9, 2017 (64)
- Volume 8, 2016 (26)
- Volume 7, 2015 (36)
- Volume 6, 2014 (20)
- Volume 5, 2013 (13)
- Volume 4, 2012 (22)
- Volume 3, 2011 (16)
- Volume 2, 2010 (9)
- Volume 1, 2009 (4)
Journal Articles:
- 424 records -
Rab1A-Mediated Exosomal Sorting of miR-200c Enhances Breast Cancer Lung Metastasis

Liu Y, Tang J, Qiu X, Teng LA, Sriwastva MK, Han X, Li Z, Liu M, Liu S, Da D, Li Z, Zhen L, Ren Y
Breast Cancer: Targets and Therapy 2023, 15:403-419
Published Date: 30 May 2023

Transcriptome Profiling Analysis of Breast Cancer Cell MCF-7 Treated by Sesamol
Wu J, Luo D, Xu J
Breast Cancer: Targets and Therapy 2023, 15:391-401
Published Date: 29 May 2023

Radiomics Analysis of Breast Lesions in Combination with Coronal Plane of ABVS and Strain Elastography
Ma Q, Shen C, Gao Y, Duan Y, Li W, Lu G, Qin X, Zhang C, Wang J
Breast Cancer: Targets and Therapy 2023, 15:381-390
Published Date: 26 May 2023
ITGB1BP1, a Novel Transcriptional Target of CD44-Downstream Signaling Promoting Cancer Cell Invasion
Ahmad SMS, Nazar H, Rahman MM, Rusyniak RS, Ouhtit A
Breast Cancer: Targets and Therapy 2023, 15:373-380
Published Date: 24 May 2023

Androgen Receptor Status in Triple Negative Breast Cancer: Does It Correlate with Clinicopathological Characteristics?
Dubrava AL, Kyaw PSP, Newman J, Pringle J, Westhuyzen J, La Hera Fuentes G, Shakespeare TP, Sakalkale R, Aherne NJ
Breast Cancer: Targets and Therapy 2023, 15:359-371
Published Date: 11 May 2023
Role of Surgery in Metastatic Breast Cancer: Insights from a Narrative Review
Alghamdi MAA, Esam Mahmood S
Breast Cancer: Targets and Therapy 2023, 15:349-358
Published Date: 9 May 2023
Exploring Real-World HER2-Low Data in Early-Stage Triple-Negative Breast Cancer: Insights and Implications
da Silva JL, Carvalho GDS, Zanetti de Albuquerque L, Rodrigues FR, Fernandes PV, Kischinhevsky D, de Melo AC
Breast Cancer: Targets and Therapy 2023, 15:337-347
Published Date: 8 May 2023
Comparison of the pCR Rate and DFS Among Breast Cancer Patients with Different Hormone Receptor and HER2 Statuses
Jin Y, Lan A, Dai Y, Jiang L, Liu S
Breast Cancer: Targets and Therapy 2023, 15:327-335
Published Date: 1 May 2023
Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated with Metronomic Cyclophosphamide: A Clinical and Translational Prospective Study
Mery B, Ménétrier-Caux C, Montané L, Heudel PE, Ray-Coquard I, Bachelot T, Derbel O, Augereau P, Treilleux I, Berthet J, Nkodia A, Bardin-Dit-Courageot C, Attignon V, Ferrari A, Garin G, Perol D, Caux C, Dubois B, Trédan O
Breast Cancer: Targets and Therapy 2023, 15:311-325
Published Date: 27 April 2023
Validation of a Disease-Free Survival Prediction Model Using UBE2C and Clinical Indicators in Breast Cancer Patients
Shen J, Yan H, Yang C, Lin H, Li F, Zhou J
Breast Cancer: Targets and Therapy 2023, 15:295-310
Published Date: 25 April 2023

Can Patients with HER2-Low Breast Cancer Benefit from Anti-HER2 Therapies? A Review
Wang J, Liao D, Zhang X, Miao C, Chen K
Breast Cancer: Targets and Therapy 2023, 15:281-294
Published Date: 21 April 2023
Breast Cancer Awareness Among Medical Students, University of Bisha, Saudi Arabia
Miskeen E, Al-Shahrani AM
Breast Cancer: Targets and Therapy 2023, 15:271-279
Published Date: 17 April 2023
Psychosocial Problems of Rural Indian Women Practising Breast Self-Examination – a Community-Based Study from Southern India
Balaiah Mehanathan P, Arthur Edwards Dennison A, Vikramathithan Panchapooranam A, Kandasamy S, Subbiah P, Velappan L, Kalyanaraman S
Breast Cancer: Targets and Therapy 2023, 15:263-270
Published Date: 17 April 2023

Progranulin and Breast Cancer Mortality: 13-Year Follow-Up of a Cohort Study
Koo DH, Lee KS, Sim SH, Chae H, Lee EG, Han JH, Jung SY, Lee S, Kang HS, Lee ES, Park CY, Oh SW
Breast Cancer: Targets and Therapy 2023, 15:251-261
Published Date: 14 April 2023
Clinicopathological Features and Survival Outcomes of Metaplastic Breast Carcinoma – An Observational Multi-Centric Study
Sherwani M, Vohra L, Ali D, Soomro R, Adnan S, Idrees R
Breast Cancer: Targets and Therapy 2023, 15:237-250
Published Date: 27 March 2023
Re-Evaluating the Association Between Hormonal Contraception and Breast Cancer Risk
Satish S, Moore JF, Littlefield JM, Bishop IJ, Rojas KE
Breast Cancer: Targets and Therapy 2023, 15:227-235
Published Date: 22 March 2023
Identification of GZMA as a Potential Therapeutic Target Involved in Immune Infiltration in Breast Cancer by Integrated Bioinformatical Analysis
Huo Q, Ning L, Xie N
Breast Cancer: Targets and Therapy 2023, 15:213-226
Published Date: 10 March 2023
Chromosomal Instability as Enabling Feature and Central Hallmark of Breast Cancer
Castellanos G, Valbuena DS, Pérez E, Villegas VE, Rondón-Lagos M
Breast Cancer: Targets and Therapy 2023, 15:189-211
Published Date: 9 March 2023
Significance of Nuclear Factor-Kappa B (NF-κB) and Survivin in Breast Cancer and Their Association with Radiosensitivity and Prognosis
Cao Q, Ai XQ, Mushajiang M
Breast Cancer: Targets and Therapy 2023, 15:175-188
Published Date: 9 March 2023
Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with BRCA1 or BRCA2 Germline Mutation?
Emiroglu S, Özkurt E, Cabıoglu N, Igci A, Saip P, Yazici H, Ozmen T, Ozmen V, Muslumanoglu M, Tukenmez M
Breast Cancer: Targets and Therapy 2023, 15:163-173
Published Date: 21 February 2023
Cost-Effectiveness of Abemaciclib in Early Breast Cancer Patients: One Size Fits All or Tailoring to Patients’ Needs?
Jongbloed EM, Blommestein HM, van Schoubroeck HM, Martens JW, Wilting SM, Uyl-de Groot CA, Jager A
Breast Cancer: Targets and Therapy 2023, 15:147-161
Published Date: 16 February 2023
The Prognostic Role of HuR Varies Between Different Subtypes of Breast Cancer Patients: Data Mining and Retrospective Analysis
Liao Y, Liao Y, Li J, Li Y, Fan Y
Breast Cancer: Targets and Therapy 2023, 15:135-146
Published Date: 11 February 2023
Factors Predicting Positive Sentinel Lymph Node Biopsy in Clinically Node-Negative Breast Cancer [Response to Letter]
AlSumai TS, Alhefdhi A
Breast Cancer: Targets and Therapy 2023, 15:133-134
Published Date: 6 February 2023
Optimized Radiomics Nomogram Based on Automated Breast Ultrasound System: A Potential Tool for Preoperative Prediction of Metastatic Lymph Node Burden in Breast Cancer
Li N, Song C, Huang X, Zhang H, Su J, Yang L, He J, Cui G
Breast Cancer: Targets and Therapy 2023, 15:121-132
Published Date: 5 February 2023
An Magnetic-Targeting Nano-Diagnosis and Treatment Platform for TNBC
Zhang M, Bao S, Qiu G, Liang J, Wang Q, Zhu X, Qin G, Liu J, Zhao C
Breast Cancer: Targets and Therapy 2023, 15:101-119
Published Date: 3 February 2023
Assessment of Knowledge and Awareness About Breast Self-Examination Among University Female Students in Saudi Arabia
Albeshan S, Shubayr N, Alashban Y
Breast Cancer: Targets and Therapy 2023, 15:91-99
Published Date: 1 February 2023
Breast Cancer Management in the Era of Covid-19; Key Issues, Contemporary Strategies, and Future Implications
Prodhan ASU, Islam DZ, Khandker SS, Jamiruddin MR, Abdullah A, Godman B, Opanga S, Kumar S, Sharma P, Adnan N, Pisana A, Haque M
Breast Cancer: Targets and Therapy 2023, 15:51-89
Published Date: 27 January 2023
Rhabdomyolysis Induced by the Interaction Between Ribociclib and Statins- Case Report and Literature Review
Badran O, Abu Amna M, Turgeman I, Bar-Sela G
Breast Cancer: Targets and Therapy 2023, 15:47-50
Published Date: 24 January 2023

Recurrent Metaplastic Breast Cancer with Subtype Converted from Triple-Negative to HER2-Positive: A Case Report and Literature Review
Wu J, Jin Y, Liu M, Zhu N, Jing Z, Zeng X
Breast Cancer: Targets and Therapy 2023, 15:39-45
Published Date: 19 January 2023
Critical Evaluation of Secondary Cancer Risk After Breast Radiation Therapy with Hybrid Radiotherapy Techniques
Zhang Q, Zeng Y, Peng Y, Yu H, Zhang S, Wu S
Breast Cancer: Targets and Therapy 2023, 15:25-38
Published Date: 23 January 2023
Dual Target of EGFR and mTOR Suppresses Triple-Negative Breast Cancer Cell Growth by Regulating the Phosphorylation of mTOR Downstream Proteins
Ma J, Dong C, Cao YZ, Ma BL
Breast Cancer: Targets and Therapy 2023, 15:11-24
Published Date: 17 January 2023
Guideline-Based, Multi-Gene Panel Germline Genetic Testing for at-Risk Patients with Breast Cancer
Abdel-Razeq H, Abujamous L, Al-Azzam K, Abu-Fares H, Bani Hani H, Alkyam M, Sharaf B, Elemian S, Tamimi F, Abuhijla F, Edaily S, Salama O, Abdulelah H, Daoud R, Abubaker M, Al-Atary A
Breast Cancer: Targets and Therapy 2023, 15:1-10
Published Date: 13 January 2023
Chromobox Family Proteins as Putative Biomarkers for Breast Cancer Management: A Preliminary Study Based on Bioinformatics Analysis and qRT-PCR Validation
Tian H, Zhao T, Li Y, Sun N, Ma D, Shi Q, Zhang G, Chen Q, Zhang K, Chen C, Zhang Y, Qi X
Breast Cancer: Targets and Therapy 2022, 14:515-535
Published Date: 30 December 2022
Whole Genome Sequencing of Single-Circulating Tumor Cell Ameliorates Unraveling Breast Cancer Heterogeneity
Li Y, Jiang X, Zhong M, Yu B, Yuan H
Breast Cancer: Targets and Therapy 2022, 14:505-513
Published Date: 28 December 2022
Real-World Outcome and Prognostic Factors Among HER2-Positive Metastatic Breast Cancer Patients Receiving Pyrotinib-Based Therapy: A Multicenter Retrospective Analysis
Liu J, Sun X, Du Q, Yao J, Dai M, Cheng Q, Xu H, Li Y, Liu X, Zhang M, Zhou Y, Yang Y
Breast Cancer: Targets and Therapy 2022, 14:491-504
Published Date: 21 December 2022
Factors Predicting Positive Sentinel Lymph Node Biopsy in Clinically Node-Negative Breast Cancer [Letter]
Zhang JY, Xu BH
Breast Cancer: Targets and Therapy 2022, 14:489-490
Published Date: 21 December 2022
Predictive and Prognostic Value of TRIM58 Protein Expression in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy
Zheng YZ, Li JY, Ning LW, Xie N
Breast Cancer: Targets and Therapy 2022, 14:475-487
Published Date: 21 December 2022
Advances in Single-Cell Sequencing Technology and Its Applications in Triple-Negative Breast Cancer
Li M, Yan T, Wang M, Cai Y, Wei Y
Breast Cancer: Targets and Therapy 2022, 14:465-474
Published Date: 14 December 2022
Economic Evaluation of Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer in the United States
Lang Y, Wu B, Liu X
Breast Cancer: Targets and Therapy 2022, 14:453-463
Published Date: 9 December 2022
Effect of Chemotherapy on the Gut Microbiome of Breast Cancer Patients During the First Year of Treatment
Wu AH, Vigen C, Tseng C, Garcia AA, Spicer D
Breast Cancer: Targets and Therapy 2022, 14:433-451
Published Date: 9 December 2022
Advances in Antibody-Drug Conjugates in the Treatment of HER2-Positive Breast Cancer
Yu Y, Wang J, Liao D, Zhang D, Li X, Jia Y, Kong F
Breast Cancer: Targets and Therapy 2022, 14:417-432
Published Date: 9 December 2022
Pyrotinib for Elderly Patients with Advanced HER2-Positive Breast Cancer
Li Y, Ma X, Zhao Z, Li L, Gao C, Liu D, Li B, Zhao B
Breast Cancer: Targets and Therapy 2022, 14:405-415
Published Date: 6 December 2022
Metformin Inducing the Change of Functional and Exhausted Phenotypic Tumor-Infiltrated Lymphocytes and the Correlation with JNK Signal Pathway in Triple-Negative Breast Cancer
Wang R, Li Y, Zhao Y, Shi F, Zhou Q, Wu J, Lyu S, Song Q
Breast Cancer: Targets and Therapy 2022, 14:391-403
Published Date: 2 December 2022
Establishment and Validation of a Model for Disease-Free Survival Rate Prediction Using the Combination of microRNA-381 and Clinical Indicators in Patients with Breast Cancer
Shen J, Wang M, Li F, Yan H, Wang R, Zhou J
Breast Cancer: Targets and Therapy 2022, 14:375-389
Published Date: 30 November 2022
Clinical Characteristics and Survival Outcomes of Patients with De Novo Metastatic Breast Cancer
Almasri H, Erjan A, Abudawaba H, Ashouri K, Mheid S, Alnsour A, Abdel-Razeq H
Breast Cancer: Targets and Therapy 2022, 14:363-373
Published Date: 29 October 2022
Ribociclib Plus Letrozole in Italian Male Patients with Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Case Studies of Phase 3b CompLEEment-1 Trial
Caputo R, Fabi A, Romagnoli E, Baldini E, Grasso D, Fenderico N, Michelotti A
Breast Cancer: Targets and Therapy 2022, 14:351-362
Published Date: 18 October 2022
Evaluating the Fragility of Long-Term Outcomes for Neoadjuvant versus Adjuvant Chemotherapy Prescription in Early Breast Cancer: Pooled Data from 10 Randomised Clinical Trials
Davey MG, Kerin MJ
Breast Cancer: Targets and Therapy 2022, 14:343-350
Published Date: 17 October 2022
Development and Validation of an MRI Radiomics-Based Signature to Predict Histological Grade in Patients with Invasive Breast Cancer
Wang S, Wei Y, Li Z, Xu J, Zhou Y
Breast Cancer: Targets and Therapy 2022, 14:335-342
Published Date: 14 October 2022
Factors Predicting Positive Sentinel Lymph Node Biopsy in Clinically Node-Negative Breast Cancer
Alsumai TS, Alhazzaa N, Alshamrani A, Assiri S, Alhefdhi A
Breast Cancer: Targets and Therapy 2022, 14:323-334
Published Date: 11 October 2022
The Involvement of Insulin-Like Growth Factor 2 Messenger Ribonucleic Acid-Binding Protein 2 in the Regulation of the Expression of Breast Cancer-Related Genes
Gao C, Li L, Jin X, Song X, Li H, Xu X, Dong C, Ma B
Breast Cancer: Targets and Therapy 2022, 14:311-322
Published Date: 10 October 2022